WVE-N531

N/A

Report date: 2024/08/13 09:16:44

NME

Base Information

Drug NameWVE-N531

Drug Alias NameWVE-N531

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionDystrophin expression stimulantsRNA interference

TargetsNot applicable

Therapy Area/IndicationsMuscular Dystrophy, Duchenne

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesUnited KingdomJordan

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesWave Life Sciences Ltd

China Registration ClassN/A

Develop Information

Active CompaniesWave Life Sciences Ltd

Inactive CompaniesN/A

Active IndicationsMuscular Dystrophy, Duchenne

Inactive IndicationsN/A

Other Information

ATC CodeN/A